Latest clozapine Stories
EAST HANOVER, N.J., Jan. 11 /PRNewswire/ -- Novartis announced that Fanapt(TM) (iloperidone) tablets are now available for use across the US for the acute treatment of schizophrenia in adults.
A Finnish research study suggests that thousands of people with schizophrenia worldwide could have been saved if doctors had prescribed them the anti-psychotic drug clozapine.
ROCKVILLE, Md., Jan 14 /PRNewswire-USNewswire/ -- Patients ages 30 to 74 who took atypical antipsychotics such as risperidone (sold as Risperdal), quetiapine (Seroquel), olanzapine (Zyprexa) and clozapine (Clozaril) had a significantly higher risk of sudden death from cardiac arrhythmias and other cardiac causes than patients who did not take these medications, according to a new study funded by HHS' Agency for Healthcare Research and Quality.
Orexigen Therapeutics, a biopharmaceutical company focused on the treatment of obesity and other central nervous system-related disorders, has initiated its first Phase IIa clinical trial with OREX-003, a proprietary sustained release formulation of zonisamide plus olanzapine.
US-based pharmaceutical company Corcept Therapeutics has announced that Eli Lilly and Company has agreed to fund studies to test the effectiveness of Corcept's selective GRII receptor antagonist, CORT 108297, in rat models of olanzapine induced weight gain.
By Anthony J. Brown, MD NEW YORK (Reuters Health) - The drug clozapine is more effective than olanzapine or haloperidol at reducing aggressive behavior in violent patients with schizophrenia, new research shows.
NEW YORK (Reuters Health) - Treatment with clozapine, considered one of the most effective antipsychotic drugs, appears to increase the risk of developing metabolic syndrome, according to a report in the American Journal of Psychiatry.
By Karla Gale NEW YORK (Reuters Health) - The prescription of antipsychotic medications for children and adolescents in the US increased nearly 6-fold between 1993 and 2002, according to survey results.
By Gene Emery BOSTON (Reuters) - Schizophrenics who took two antipsychotic drugs showed no more improvement than those on a single drug, raising doubts about the benefit of using multiple medicines to treat the disease, a study said on Wednesday.
Schizophrenics who took two antipsychotic drugs showed no more improvement than those on a single drug, raising doubts about the benefit of using multiple medicines to treat the disease, a study said on Wednesday.
- totally perplexed and mixed up.